129 related articles for article (PubMed ID: 3100012)
1. Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Shaw RW; Matta W
Clin Reprod Fertil; 1986 Oct; 4(5):329-36. PubMed ID: 3100012
[TBL] [Abstract][Full Text] [Related]
2. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
Raitz von Frentz M; Schweppe KW
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
[TBL] [Abstract][Full Text] [Related]
3. Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH.
Okuda K; Ushiroyama T; Yoshikawa M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1889-93. PubMed ID: 3145318
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
Schindler AE; Bühler K; Mettler L; Fuchs U; Cirkel U; Ochs H; Schweppe KW; Koch R
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):569-73. PubMed ID: 8001754
[TBL] [Abstract][Full Text] [Related]
5. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.
Lemay A; Maheux R; Faure N; Jean C; Fazekas AT
Fertil Steril; 1984 Jun; 41(6):863-71. PubMed ID: 6427019
[TBL] [Abstract][Full Text] [Related]
6. Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
Minaguchi H; Uemura T; Shirasu K
Prog Clin Biol Res; 1986; 225():211-25. PubMed ID: 3097667
[No Abstract] [Full Text] [Related]
7. [Residual endometriosis following LHRH analog therapy].
Ochs H; Cirkel U; Schweppe KW; Schneider HP
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):140-4. PubMed ID: 2108075
[TBL] [Abstract][Full Text] [Related]
8. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
Lemay A; Labrie F; Raynaud JP
Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
Lemay A; Maheux R; Jean C; Faure N
Prog Clin Biol Res; 1986; 225():157-73. PubMed ID: 3097663
[No Abstract] [Full Text] [Related]
10. Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
Sirimongkolkasem R; Rojanasakul A; Chailurkit LO
J Med Assoc Thai; 1990 Feb; 73 Suppl 1():37-41. PubMed ID: 2112582
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
Zorn JR; Tanger C; Roger M; Grenier J; Comaru-Schally AM; Schally AV
Int J Fertil; 1986; 31(1):11-3, 16-27. PubMed ID: 2908272
[TBL] [Abstract][Full Text] [Related]
12. [Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
Hardt W; Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Genz T; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):483-9. PubMed ID: 3093311
[TBL] [Abstract][Full Text] [Related]
13. The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).
Franssen AM; Kauer FM; Rolland R; Zijlstra JA; Willemsen WN; van 't Veen AJ
Prog Clin Biol Res; 1986; 225():201-10. PubMed ID: 3097666
[No Abstract] [Full Text] [Related]
14. [Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
Nakamura Y; Yoshimura Y; Yamada H; Maruyama K; Nanno T; Ubukata Y; Ando M; Takahashi K; Suzuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1620-6. PubMed ID: 2126024
[TBL] [Abstract][Full Text] [Related]
15. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
Healy DL; Lawson SR; Abbott M; Baird DT; Fraser HM
J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of endometriosis with domestic luteinizing hormone--releasing hormone analogue].
Geng L; Gu FY; Zhang LZ
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):592-4, 636. PubMed ID: 7712871
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal changes in buserelin therapy].
Fuchs U; Zwirner M
Zentralbl Gynakol; 1989; 111(18):1236-40. PubMed ID: 2511705
[TBL] [Abstract][Full Text] [Related]
18. Uterine leiomyoma: treatment with LHRH agonist.
Maheux R; Lemay A
Prog Clin Biol Res; 1986; 225():297-311. PubMed ID: 3097669
[No Abstract] [Full Text] [Related]
19. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
20. LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation.
Cirkel U; Schweppe KW; Ochs H; Hanker JP; Schneider HP
Arch Gynecol Obstet; 1989; 246(3):139-51. PubMed ID: 2515811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]